€17.26
1.37% today
Xetra, Jul 01, 09:45 am CET
ISIN
DE000EVNK013
Symbol
EVK
Index
Industry

Evonik Stock price

€17.50
-1.56 8.18% 1M
+0.77 4.60% 6M
+0.77 4.60% YTD
-1.39 7.33% 1Y
-2.86 14.05% 3Y
-5.11 22.60% 5Y
-16.73 48.87% 10Y
-15.44 46.87% 20Y
Xetra, Closing price Mon, Jun 30 2025
-0.83 4.53%
ISIN
DE000EVNK013
Symbol
EVK
Index
Industry

Key metrics

Basic
Market capitalization
€8.5b
Enterprise Value
€11.8b
Net debt
€3.3b
Cash
€1.3b
Shares outstanding
466.0m
Valuation (TTM | estimate)
P/E
27.34 | 11.16
P/S
0.56 | 0.55
EV/Sales
0.78 | 0.76
EV/FCF
12.54
P/B
0.89
Dividends
DPS
€1.17
Yield 1Y | 5Y
6.69% | 5.37%
Growth 1Y | 5Y
0.00% | 0.35%
Payout 1Y | 3Y
243.75% | 548.44%
Increased
0 Years
Financials (TTM | estimate)
Revenue
€15.1b | €15.5b
EBITDA
€1.7b | €2.1b
EBIT
€604.0m
Net Income
€299.0m | €730.4m
Free Cash Flow
€941.0m
Growth (TTM | estimate)
Revenue
0.53% | 1.95%
EBITDA
-4.93% | -0.75%
EBIT
5,590.91%
Net Income
183.99% | 229.02%
Free Cash Flow
3.75%
Margin (TTM | estimate)
Gross
24.74%
EBITDA
11.20% | 13.75%
EBIT
3.99%
Net
1.98% | 4.73%
Free Cash Flow
6.22%
Financial Health
Equity Ratio
45.67%
Return on Equity
2.46%
ROCE
3.76%
ROIC
2.50%
Debt/Equity
0.50
More
EPS
€0.64
FCF per Share
€2.02
Short interest
-
Employees
30.67k
Rev per Employee
€490.00k
Show more

Is Evonik a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,948 stocks worldwide.

Evonik Stock Analysis

Unlock Scores for Free

Analyst Opinions

22 Analysts have issued a Evonik forecast:

13x Buy
59%
6x Hold
27%
3x Sell
14%

Analyst Opinions

22 Analysts have issued a Evonik forecast:

Buy
59%
Hold
27%
Sell
14%

Financial data from Evonik

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
15,138 15,138
1% 1%
100%
- Direct Costs 11,393 11,393
1% 1%
75%
3,745 3,745
6% 6%
25%
- Selling and Administrative Expenses 2,611 2,611
13% 13%
17%
- Research and Development Expense 454 454
8% 8%
3%
1,696 1,696
5% 5%
11%
- Depreciation and Amortization 1,092 1,092
39% 39%
7%
EBIT (Operating Income) EBIT 604 604
5,591% 5,591%
4%
Net Profit 299 299
184% 184%
2%

In millions EUR.

Don't miss a Thing! We will send you all news about Evonik directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Evonik Stock News

AD HOC NEWS
about one month ago
Die US-Investmentbank Goldman Sachs hat das Kursziel für Evonik DE000EVNK013 von 18,90 auf 20,00 Euro angehoben, aber die Einstufung auf "Neutral" belassen.
AD HOC NEWS
about one month ago
Deutsche Bank Research hat das Kursziel für Evonik DE000EVNK013 von 23 auf 25 Euro angehoben und die Einstufung auf "Buy" belassen.
AD HOC NEWS
about one month ago
Der Spezialchemiekonzern Evonik DE000EVNK013 will mit dem größten Umbau seiner Firmengeschichte den operativen Gewinn in den kommenden deutlich steigern.
More Evonik News

Company Profile

Evonik Industries AG is a holding company, which engages in the manufacture of specialty chemical products. It operates through the following segments: Nutrition and Care, Resource Efficiency, Performance Materials, Services, and Other Operations. The Nutrition and Care segment produces specialty chemicals, principally for use in consumer goods for daily needs, and in animal nutrition and healthcare products. The Resource Efficiency segment supplies materials and specialty additives for environment-friendly and energy-efficient system solutions for the automotive, paints, coatings, adhesives, construction industries, and other sectors. The Performance Materials segment manufacture polymer materials and intermediates, mainly for the rubber, plastics, and agriculture industries. The Services segment comprises site management, utilities, waste management, technical, process technology, engineering, and logistics services for the chemical segments and external customers. The Other Operation segment consists management holding company, strategic research, and hidden reserves and liabilities. The company was founded in 1919 and is headquartered in Essen, Germany.

Head office Germany
CEO Christian Kullmann
Employees 30,669
Founded 1919
Website corporate.evonik.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today